Comparison of Modified Posterior Sub-Tenon’s vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis

References

• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844–848. doi:https://doi.org/10.1136/bjo.80.9.844.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303–308.
   PubMed Web of Science ®Google Scholar
• Darrell RW. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol. 1962;68:502–514. doi:https://doi.org/10.1001/archopht.1962.00960030506014.
   PubMed Web of Science ®Google Scholar
• Goldstein H. The reported demography and causes of blindness throughout the world. Adv Ophthalmol. 1980;40:1–99.
   PubMedGoogle Scholar
• Gaudio PA. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm. 2004;12(3):169–192. doi:https://doi.org/10.1080/092739490500192.
   PubMed Web of Science ®Google Scholar
• Weijtens O, Feron EJ, Schoemaker RC, et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128(2):192–197. doi:https://doi.org/10.1016/S0002-9394(99)00129-4.
   PubMed Web of Science ®Google Scholar
• Weijtens O, van der Sluijs FA, Schoemaker RC, et al. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123(3):358–363. doi:https://doi.org/10.1016/S0002-9394(14)70131-X.
   PubMed Web of Science ®Google Scholar
• Nozik RA. Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:695–705.
   PubMedGoogle Scholar
• Ferrante P, Ramsey A, Bunce C, Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Exp Ophthalmol. 2004;32(6):563–568. doi:https://doi.org/10.1111/ceo.2004.32.issue-6.
   PubMed Web of Science ®Google Scholar
• Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol. 2011;152(3):441–448.e442. doi:https://doi.org/10.1016/j.ajo.2011.02.009.
   PubMed Web of Science ®Google Scholar
• Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-Tenon’s corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997;104(12):2003–2008. doi:https://doi.org/10.1016/S0161-6420(97)30065-7.
   PubMed Web of Science ®Google Scholar
• Smith JR, George RK, Rosenbaum JT. Lower eyelid herniation of orbital fat may complicate periocular corticosteroid injection. Am J Ophthalmol. 2002;133(6):845–847. doi:https://doi.org/10.1016/S0002-9394(02)01412-5.
   PubMed Web of Science ®Google Scholar
• Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–425. doi:https://doi.org/10.4103/2229-5178.142483.
   PubMedGoogle Scholar
• Morgan CM, Schatz H, Vine AK, et al. Ocular complications associated with retrobulbar injections. Ophthalmology. 1988;95(5):660–665. doi:https://doi.org/10.1016/S0161-6420(88)33130-1.
   PubMed Web of Science ®Google Scholar
• Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon’s triamcinolone injections in the treatment of uveitis. Eye (Lond). 1998;12(Pt 4):679–685. doi:https://doi.org/10.1038/eye.1998.168.
   PubMed Web of Science ®Google Scholar
• Chew EY, Glassman AR, Beck RW, et al. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema. Retina (Philadelphia, Pa). 2011;31(2):284–289. doi:https://doi.org/10.1097/IAE.0b013e3181f049a8.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Zhang Y, et al. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study. Retina (Philadelphia, Pa). 2012;32(9):1838–1843. doi:https://doi.org/10.1097/IAE.0b013e31824fd384.
   PubMed Web of Science ®Google Scholar
• Chew E, Strauber S, Beck R, et al. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: apilot study. Ophthalmology. 2007;114(6):1190–1196.
   Google Scholar
• Hanson RJ, Downes S. Conservative management of refractory steroid-induced glaucoma following anterior subtenon steroid injection. Clin Exp Ophthalmol. 2007;35(2):197–198. author reply 198. doi:https://doi.org/10.1111/j.1442-9071.2007.01475.x.
   PubMed Web of Science ®Google Scholar
• Athanasiadis Y, Nithyanandrajah GA, Kumar B, Sharma A. Reversal of steroid induced raised intraocular pressure following removal of subconjunctival triamcinolone for cataract surgery. Cont Lens Anterior Eye. 2009;32(3):143–144. doi:https://doi.org/10.1016/j.clae.2008.08.004.
   Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
   Google Scholar
• Nussenblatt RBWS, Palestine AG. Uveitis: Fundamentals and Clinical Practice. 2nd. New York, NY: Mosby; 1996.
   Google Scholar
• Xu X, Han Y, Kong L, Ding X, Liu F, Cheng L. Clinical implication of triamcinolone in aqueous humor after depository sub-Tenon application. J Cataract Refract Surg. 2017;43(11):1383–1390. doi:https://doi.org/10.1016/j.jcrs.2017.08.010.
   PubMed Web of Science ®Google Scholar
• Jea SY, Byon IS, Oum BS. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis. Korean J Ophthalmol. 2006;20(2):99–103. doi:https://doi.org/10.3341/kjo.2006.20.2.99.
   PubMedGoogle Scholar
• Sen HN, Vitale S, Gangaputra SS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121(11):2275–2286. doi:https://doi.org/10.1016/j.ophtha.2014.05.021.
   PubMed Web of Science ®Google Scholar
• Iwao K, Inatani M, Kawaji T, Koga T, Mawatari Y, Tanihara H. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma. 2007;16(2):251–256. doi:https://doi.org/10.1097/IJG.0b013e31802d696f.
   PubMed Web of Science ®Google Scholar
• Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP. Posterior sub-Tenon’s steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol. 1999;237(4):289–295. doi:https://doi.org/10.1007/s004170050235.
   PubMed Web of Science ®Google Scholar
• Akduman L, Kolker AE, Black DL, Del Priore LV, Kaplan HJ. Treatment of persistent glaucoma secondary to periocular corticosteroids. Am J Ophthalmol. 1996;122(2):275–277. doi:https://doi.org/10.1016/S0002-9394(14)72027-6.
   PubMed Web of Science ®Google Scholar
• Kalina PH. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995;113(7):867–869. doi:https://doi.org/10.1001/archopht.1995.01100070041022.
   PubMedGoogle Scholar